Last updated: 2021 Jul 2
Total hit(s): 1
Select item(s)
Key Findings
(You can add your comments too!)
Original Article
(hover to see details)
A comparative cohort study was conducted on COVID 19 samples from two different variants Daxing B.1.1.7 and Shunyi B.1.470, to determine the clinical freatures of B.1.1.7 variant. 7 clinical features-fever, C-reactive protein, d-dimmer, serum Amyloid A, creative kinase, CD4+ T lymphocyte and ground glass opacity was more in the Daxing group (B.1.1.7) when compared to the Shunyi B.1.470 group Limitations of this study are - 1. Small sample size of the two groups and 2. Clinical feature of B.1.1.7 variant was not compared with SARS-COV2 variant other than B.1.470.
Pre-print ( medRXiv )
Date of Publishing 2021 May 08
Title COVID-19 cases from the first local outbreak of SARS-CoV-2 B.1.1.7 variant in China presented more serious clinical features: a prospective, comparative cohort study
Impact factor
Date of Entry 2021 Jul 2